- Home
- Publications
- Publication Search
- Publication Details
Title
Antiplatelet drug interactions with proton pump inhibitors
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 10, Issue 2, Pages 175-189
Publisher
Informa Healthcare
Online
2013-11-09
DOI
10.1517/17425255.2014.856883
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors
- (2013) Wayne A. Ray ANNALS OF INTERNAL MEDICINE
- CYP2C19 Genetic Polymorphism, Rabeprazole and Esomeprazole Have no Effect on the Antiplatelet Action of Clopidogrel
- (2013) Mustapha M. El-Halabi et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- TheCYP2C19*17 variant is not independently associated with clopidogrel response
- (2013) J. P. Lewis et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Adverse Cardiovascular Effects of Concomitant Use of Proton Pump Inhibitors and Clopidogrel in Patients with Coronary Artery Disease: A Systematic Review and Meta-Analysis
- (2012) Baotao Huang et al. ARCHIVES OF MEDICAL RESEARCH
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack
- (2012) Stefan K. James et al. CIRCULATION
- Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes
- (2012) Steen Husted et al.
- Clopidogrel: A Case for Indication-Specific Pharmacogenetics
- (2012) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- An insight into the Interaction between Clopidogrel and Proton Pump Inhibitors
- (2012) Bhavik S. Shah et al. CURRENT DRUG METABOLISM
- CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers
- (2012) Barbara Gawrońska-Szklarz et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Ticagrelor: the first novel reversible P2Y12inhibitor
- (2012) Wah Wah Htun et al. EXPERT OPINION ON PHARMACOTHERAPY
- No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: Meta-analysis
- (2012) Chun Shing Kwok et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers
- (2012) Andrew L. Frelinger et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel Maintenance Dosing in Aspirin-Treated Patients With Stable Coronary Disease
- (2012) Matthew J. Price et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes
- (2012) S Martis et al. PHARMACOGENOMICS JOURNAL
- Esomeprazole but Not Pantoprazole is Associated with Lower Plasma Concentrations of Clopidogrel's Active Metabolite
- (2011) Ankie M Harmsze et al. ANNALS OF PHARMACOTHERAPY
- A Meta-Analysis of Impact of Proton Pump Inhibitors on Antiplatelet Effect of Clopidogrel
- (2011) Mao Chen et al. Cardiovascular Therapeutics
- Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction
- (2011) Tabassome Simon et al. CIRCULATION
- CYP2C19 Genotype and Proton Pump Inhibitors in Clopidogrel-Treated Patients
- (2011) Michelle L. O'Donoghue CIRCULATION
- Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record
- (2011) J T Delaney et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy
- (2011) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
- (2011) Edward Sheen et al. DIGESTIVE DISEASES AND SCIENCES
- Lack of Significant Interactions Between Clopidogrel and Proton Pump Inhibitor Therapy: Meta-Analysis of Existing Literature
- (2011) Lauren B. Gerson et al. DIGESTIVE DISEASES AND SCIENCES
- High Doses of Clopidogrel to Overcome Genetic Resistance
- (2011) Jean-Philippe Collet et al. JACC-Cardiovascular Interventions
- CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events
- (2011) Michael V. Holmes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis
- (2011) Guillaume Cayla et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High On-Treatment Platelet Reactivity After Prasugrel Loading Dose and Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes
- (2011) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention
- (2011) A. M. HARMSZE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- PharmGKB summary
- (2011) Stuart A. Scott et al. Pharmacogenetics and Genomics
- Update on the pharmacogenomics of proton pump inhibitors
- (2011) Krisztina Hagymási et al. PHARMACOGENOMICS
- Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel
- (2011) Wiktor Kuliczkowski et al. THROMBOSIS AND HAEMOSTASIS
- Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping
- (2010) S. Miehlke et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Risk of Rehospitalization for Patients Using Clopidogrel With a Proton Pump Inhibitor
- (2010) Karen M. Stockl ARCHIVES OF INTERNAL MEDICINE
- Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes
- (2010) Takahisa Furuta et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacodynamic Effects of Concomitant Versus Staggered Clopidogrel and Omeprazole Intake
- (2010) José L. Ferreiro et al. Circulation-Cardiovascular Interventions
- Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies
- (2010) D J Angiolillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of Proton Pump Inhibitors on Adverse Gastrointestinal Events in Patients Receiving Clopidogrel
- (2010) Chun Shing Kwok et al. DRUG SAFETY
- Influence of CYP2C19 on the relationship between pharmacokinetics and intragastric pH of omeprazole administered by successive intravenous infusions in Chinese healthy volunteers
- (2010) Yongqing Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole
- (2010) Jeong Hoon Lee et al. Gut and Liver
- Effects of Omeprazole on the Antiplatelet Activity of Clopidogrel
- (2010) Kyeong Ho Yun et al. International Heart Journal
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The effect of cytochrome P2C19 and interleukin-1 polymorphisms on H. pylori eradication rate of 1-week triple therapy with omeprazole or rabeprazole, amoxycillin and clarithromycin in Chinese people
- (2010) L. Zhang et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
- (2010) Jean-Sébastien Hulot et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2010) Neena S. Abraham et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis
- (2010) J. M. SILLER-MATULA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
- (2010) Jessica L Mega et al. LANCET
- Clopidogrel with or without Omeprazole in Coronary Artery Disease
- (2010) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
- (2010) F Sofi et al. PHARMACOGENOMICS JOURNAL
- Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study
- (2010) Rolf P Kreutz et al. PHARMACOTHERAPY
- Mode of action of P2Y12 antagonists as inhibitors of platelet function
- (2010) D. Iyú et al. THROMBOSIS AND HAEMOSTASIS
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
- (2009) D. N. Juurlink et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
- (2009) Jessica L. Mega et al. CIRCULATION
- Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
- (2009) Shu-Feng Zhou CLINICAL PHARMACOKINETICS
- Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite
- (2009) M. Kazui et al. DRUG METABOLISM AND DISPOSITION
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON-TIMI 38
- (2009) Rebecca E. Wrishko et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
- (2009) Nagy A. Farid et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects
- (2009) J.-S. HULOT et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
- (2009) Michelle L O'Donoghue et al. LANCET
- Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
- (2008) Jolanta M. Siller-Matula et al. AMERICAN HEART JOURNAL
- Effect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians
- (2008) Nicole G. Hunfeld et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2008) et al. CIRCULATION
- Incidence of Death and Acute Myocardial Infarction Associated With Stopping Clopidogrel After Acute Coronary Syndrome
- (2008) P. Michael Ho JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel
- (2008) David S. Small et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Initial Assessment of Clinical Impact of a Drug Interaction Between Clopidogrel and Proton Pump Inhibitors
- (2008) Edmund Pezalla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
- (2008) Martine Gilard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
- (2008) Jean-Philippe Collet et al. LANCET
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started